Trial Profile
Post Marketing Surveillance on Long-term Use With Norditropin (Short Stature Due to Noonan Syndrome)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Nov 2022
Price :
$35
*
At a glance
- Drugs Somatropin (Primary)
- Indications Noonan syndrome; Short stature
- Focus Adverse reactions
- Sponsors Novo Nordisk
- 02 Feb 2022 Status changed from active, no longer recruiting to completed.
- 02 Jul 2020 Status changed from recruiting to active, no longer recruiting.
- 05 Mar 2018 Status changed from not yet recruiting to recruiting.